期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌新辅助内分泌治疗进展 被引量：1

下载PDF
导出
摘要 乳腺癌的新辅助内分泌治疗是治疗激素依赖性乳腺癌的重要手段之一,本文分别对新辅助内分泌治疗的概括、常用药物、合理疗程及耐药机制和对策等方面予以归纳。
作者 夏璐 冀学宁
机构地区 遵义医学院 大连大学附属中山医院
出处 《中国医学创新》 CAS 2012年第24期160-161,共2页 Medical Innovation of China
关键词 乳腺癌 新辅助内分泌治疗 耐药
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1Jordan V C. Tamoxifen: a most unlikely pioneering medicine[J]. Nat Rev Drug Discov, 2003, 2(3):205.
  • 2Gradishar W J. Recently initiated studies: neoadjuvant treatments in next century[J]. Semi Oncol, 1999, 26(1 suppl 3):26.
  • 3Valenzuela M, Julian T B. Neo-adjuvant hormonal therapy[J]. Breast J, 2008, 14(3):279-283.
  • 4Bross P F, Baird A, Chen G, et al. Fulvestrant in postmenopausal women with advanced breast cancer[J]. Clin Cancer Res, 2003, 9(12):4309-4317.
  • 5Miller W R, Dixon J M. Local endocrine effects of aromatase inhibitors within the berast[J]. J SteroidBiochem Mol Biol, 2001, 79(1-5):93.
  • 6Krainick-Strobel U E, Lich tenegger W, Wallwiener D, et al. Neoadjuvant let rozole in postmenopausal estrogen and/or progesterone recept or positive breast cancer: a phase II b/ E trial to invest igateoptimal duration of preoperative endocrine therapy[J]. BMC Cancer, 2008, 26(8):62.
  • 7Fan J, Yin W J, Lu J S, et al. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor[J]. Cancer Res Clin Oncol, 2008, 134(1):883-890.
  • 8Borgquist S, Holm C, Stendahl M, et al. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer[J]. J Clin Pathol, 2008, 61(2):197-203.
  • 9袁翔,程昕,许元富,周圆,邵晓枫,李巍,任思楣,张秀丽,杨铭.降低细胞膜角蛋白8和乳腺癌耐药蛋白的表达逆转耐药性[J].中国药理学通报,2009,25(11):1425-1429. 被引量：5
  • 10Perey L, Paridaens R, Hawle H. Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatas.e inhibitors: final results of phase ]I Swiss Group for Clinical Cancer Research TriaI(SAK21/00)[J]. Ann Oncol, 2007, 18(1):64-69.

二级参考文献20

共引文献5

同被引文献17

  • 1邵牧民,孟刚,龚西騟.乳腺大汗腺癌的形态学与免疫表型特征[J].临床与实验病理学杂志,2005,21(1):14-19. 被引量：14
  • 2Bedford T, Alperstein A, Nathani Y, et al. A rare presentation of triple-negative apocrine breast carcinoma with metastases[J]. J Surg Case Rep, 2014, 15 ( 1 ) : 20-30.
  • 3Femandez-Flores A. Immunohistochemical and morphologic evaluation of primary cutaneous apocrine carcinomas and cutaneous metastases from ductal breast carcinoma[J]. Rom J Morphol Embryol, 2012,53( 4 ): 879-892.
  • 4Yerushalmi R, Hayes M M, Gelmon K A. Breast carcinoma-rare types: review of the literature[J]. Annals of Oncology, 2009, 20 ( 11 ): 1763-1770.
  • 5Wader J V, Jain A, Bhosale S J, et al. Apocrine carcinoma of breast: a case report with review of the literature[J]. Case Rep Pathol, 2013, 1 ( 2 ) : 170918.
  • 6Naito Y, Yamaguehi R, Tanaka M, et al. Squamous cell carcinoma with apocrine features of the breast : A case report[J]. Oneol Lett, 2014, 7 (3) : 647-650.
  • 7Japaze H, Emina J, Diaz C, et al. ' Pure' invasive apocrine carcinoma of the breast: a new elinieopathologieal entity?[J]. Breast, 2005, ld( 1 ): 3-10.
  • 8Huo L, Zhang J, Gilcrease M Z, et al. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer[J]. Histopathology, 2013, 62 ( 2 ) : 267-274.
  • 9Tsutsumi Y. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesteronereceptor-negative and androgen receptor-positive invasive ductal carcinoma[J]. Japanese Journal of Clinical Oncology, 2012, 42 ( 5 ) : 375-386.
  • 10Durham J R, Fechner R E. The histologic spectrum of apocrine lesions of the breast[J]. The American Journal of Clinical Pathology, 2000, 13 (suppl 1 ) : 18.

引证文献1

中国医学创新
2012年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部